No increase of the fibrinolytic activity of the human endometrium by progesterone-releasing IUD (ProgestasertR).
An increase in menstrual blood loss  is one of the most common side effects of plastic IUDs and, though less often, also of copper IUDs. This has been explained by the observation that IUD enhances the fibrinolytic activity of the endometrium. A progesterone-releasing IUD (ProgestasertR) does not increase menstrual bleeding. The fibrinolytic activity of the endometrium was studied in 17 women before and after insertion of a progesterone-releasing IUD. It did not enhance the histochemically determined fibrinolytic activity in the endometrium.
D004717:Endometrium / Q000502:physiology*; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D007435:Intrauterine Devices, Copper; D011374:Progesterone / Q000494:pharmacology*
D011374:Progesterone